as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
0.82%
Downside
2.18%
Upside
52 Week's Low
52 Week's High
32.14%
Downside
24.12%
Upside
Check Teva Pharmaceutical Industries Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$18.8B
EPS (TTM)
2.5815
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
30.17
Industry PE ratio
16.65525641025641
P/B Ratio
0PEG Ratio
1.2934
EBITDA
-
Revenue (TTM)
-
Profit Margin
-0.94%
Return On Equity TTM
-2.42%
Track how Teva Pharmaceutical Industries Ltd P/E has moved over time to understand its valuation trends.
Teva Pharmaceutical Industries Ltd in the last 5 years
Lowest (3.34x)
March 31, 2022
Industry (16.66x)
September 17, 2025
Today (30.17x)
September 17, 2025
Highest (7.31x)
December 31, 2024
Today’s Price to Earnings Ratio: 30.17x
Compare market cap, revenue, PE, and other key metrics of Teva Pharmaceutical Industries Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
$18.8B | 103.34% | 30.17 | -0.94% | ||
BUY | $18.0B | NA | 15.52 | 40.36% | |
BUY | $44.0B | NA | 21.51 | 13.81% | |
BUY | $14.0B | 38.31% | 41.69 | 13.88% | |
BUY | $65.4B | -8.86% | 25.38 | 27.83% |
The Teva Pharmaceutical Industries Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Teva Pharmaceutical Industries Ltd investment value today
Current value as on today
₹1,07,511
Returns
₹7,511
(+7.51%)
Returns from Teva Pharmaceutical Industries Ltd Stock
₹2,913 (+2.91%)
Dollar Returns*
₹4,598 (+4.6%)
Based on 9 analysts
0.00%
Buy
33.33%
Hold
66.67%
Sell
Based on 9 analysts, 66.67% of analysts recommend a 'SELL' rating for Teva Pharmaceutical Industries Ltd. Average target price of $23.44
Get share price movements and forecasts by analysts on Teva Pharmaceutical Industries Ltd.
What analysts predicted
21.63%UPSIDE
Target Price
$23.44
Current Price
$18.37
Analyzed by
9 Analysts
Target
$23.44
Teva Pharmaceutical Industries Ltd target price $23.44, a slight upside of 21.63% compared to current price of $18.37. According to 9 analysts rating.
Search interest for Teva Pharmaceutical Industries Ltd Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:34% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, TEVA has outperformed top 5 stocks with highest market-cap in its industry
Profit Spike
Netprofit is up for the last 5 quarters, -845.0M → 282.0M (in $), with an average increase of 105.1% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 3.89B → 4.17B (in $), with an average increase of 6.8% per quarter
Against Peers
In the last 1 year, Neurocrine Biosciences Inc. has given 17.6% return, outperforming this stock by 13.1%
Price Dip
In the last 7 days, TEVA stock has moved down by -6.1%
Organisation | Teva Pharmaceutical Industries Ltd |
Headquarters | 124 Dvora HaNevi?a St., Tel Aviv, Israel, 6944020 |
Industry | Health Technology |
CEO | Mr. Richard D. Francis |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Christopher J. Stevo CFA | Senior Vice President of Investor Relations & Competitive Intelligence |
Dr. Eric A. Hughes M.D., Ph.D. | Executive VP of Global R&D and Chief Medical Officer |
Kathleen Veit | Senior Vice President, Global Compliance & Ethics Officer |
Ms. Christine Fox | Executive VP of U.S. Commercial Business |
Mr. Matthew Shields | Executive Vice President of Global Operations |
Mr. Amir Weiss | Senior VP & Chief Accounting Officer |
Mr. Richard Gordon Daniell | Executive Vice President of European Commercial |
Mr. David R. Mcavoy J.D. | Executive VP & Chief Legal Officer |
Mr. Eliyahu Sharon Kalif | Executive VP & CFO |
Mr. Richard D. Francis | President, CEO & Director |
Teva Pharmaceutical Industries Ltd share price today is $18.37 as on at the close of the market. Teva Pharmaceutical Industries Ltd share today touched a day high of $18.77 and a low of $18.22.
Teva Pharmaceutical Industries Ltd share touched a 52 week high of $22.8 on and a 52 week low of $12.47 on . Teva Pharmaceutical Industries Ltd stock price today i.e. is closed at $18.37,which is 19.43% down from its 52 week high and 47.37% up from its 52 week low.
Teva Pharmaceutical Industries Ltd market capitalisation is $0.02T as on .
Indian investors can start investing in Teva Pharmaceutical Industries Ltd (TEVA) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Teva Pharmaceutical Industries Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Teva Pharmaceutical Industries Ltd share’s latest price of $18.37 as on September 18, 2025 at 1:29 am IST, you will get 0.5444 shares of Teva Pharmaceutical Industries Ltd. Learn more about
fractional shares .
Teva Pharmaceutical Industries Ltd stock has given 103.34% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?